| |
|
|
|
scPharmaceuticals Inc.  
|
|
3.46 -0.06 (-0.02%) |
05-23 13:08 |
|
Open: |
3.51 |
Pre close: |
3.52 |
Target:
|
4.19 
|
|
High: |
3.51 |
Low: |
3.39 |
Resistance:
|
3.59
4.08
|
|
Volume: |
8,174 |
Market Cap: |
64M |
Support:
|
2.80
2.33
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.48
|
MACD |
MACD(12,26):
|
0.09 |
|
MA(20): |
3.51 |
Signal(12,26,9): |
0.11 |
|
MA(100): |
3.36 |
Stochastic Oscillator |
%K(14,3):
|
49.27 |
|
MA(250): |
4.56 |
%D(3): |
50.92 |
|
Average Volume(K) |
3-Month: |
5974
|
52-Week |
High:
|
14.36 |
|
10-Days: |
6603 |
Low: |
2.44 |
|
RSI |
RSI(14):
|
50.18 |
Change(%): |
-75.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.580 |
Return on Equity (ttm) |
-36.9 |
Shares Out. (M) |
18.58 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-30.8 |
Shares Float (M) |
18.49 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
45.80 |
|
Forward EPS |
-2.159 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.990 |
EBITDA (p.s.) |
0.000 |
P/E |
-2.16 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.44 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-25.86 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-15.24 |
P/CF |
-2.45 |
|
|
|
|
|
|
